November 9-11, 2020 | Virtual Conference

Speakers

Edward Sherwood

Director, Office of Regulatory Operations (ORO), OGD, CDER
FDA

Ted Sherwood returned to the Office of Generic Drugs (OGD) to serve as the Director, Office of Regulatory Operations (ORO).  ORO consists of four different divisions: the Division of Project Management, the Division of Filing Review, the Division of Labeling Review, and the Division of Quality Management Systems. Previously, he served as the Associate Director of Immediate Office Operations, Office of Pharmaceutical Science [now the Office of Pharmaceutical Quality (OPQ)].  Prior to joining OPQ in 1999, he spent a dozen years in OGD.  He held various positions including, reviewing new submissions for determination of fileability, conducting program analyses, and coordinating congressional activities.  Ted received his bachelor’s degree from the University of Maryland in 1992.

Get Started + Register

Whether you are an AAM member, general attendee, speaker or exhibitor, you can be part of the premier scientific and regulatory conference for the U.S. generics and biosimilars industry.

Get Started + Register

Whether you are an AAM member, general attendee, speaker or exhibitor, you can be part of the premier scientific and regulatory conference for the U.S. generics and biosimilars industry.

Skip to content